Share on StockTwits

Fibrocell Science (NASDAQ:FCSC) Director Christine St.Clare bought 10,000 shares of the stock in a transaction dated Thursday, June 5th. The stock was purchased at an average price of $3.00 per share, with a total value of $30,000.00. Following the completion of the acquisition, the director now directly owns 10,000 shares in the company, valued at approximately $30,000. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Fibrocell Science (NASDAQ:FCSC) opened at 3.34 on Friday. Fibrocell Science has a 52-week low of $2.70 and a 52-week high of $7.20. The stock has a 50-day moving average of $3.25 and a 200-day moving average of $4.39. The company’s market cap is $136.5 million.

Fibrocell Science (NASDAQ:FCSC) last issued its quarterly earnings data on Monday, May 19th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.20. On average, analysts predict that Fibrocell Science will post $-0.80 earnings per share for the current fiscal year.

Fibrocell Science, Inc is an aesthetic and therapeutic development stage biotechnology company focused on developing novel skin and tissue rejuvenation products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.